EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm is inviting investors who purchased ESSA Pharma Inc. (NASDAQ: EPIX) securities between December 12, 2023, and October 31, 2024, to join a securities fraud lawsuit. The deadline for lead plaintiff applications is March 25, 2025.
March 13, 2025 | 10:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a securities fraud lawsuit, and investors who purchased shares between December 12, 2023, and October 31, 2024, can join the case. The lead plaintiff deadline is March 25, 2025.
The announcement of a securities fraud lawsuit against ESSA Pharma is likely to negatively impact its stock price in the short term as it raises concerns about the company's legal and financial standing. The lawsuit could lead to financial liabilities and damage investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100